Cellebrite DI (CLBT) Other Operating Expenses (2020 - 2026)

Cellebrite DI has reported Other Operating Expenses for 7 years, with the latest figure at $36.0 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 25.69% year-over-year to $36.0 million in Q2 2026; TTM through Jun 2026 was $128.0 million, a 20.57% increase from a year earlier, with the FY2025 full-year figure at $103.1 million, up 13.37% from the prior year.
• Other Operating Expenses was $36.0 million for Q2 2026 at Cellebrite DI, up from $35.8 million in the prior quarter.
• The five-year high for Other Operating Expenses was $36.0 million in Q2 2026, with the low at $17.9 million in Q4 2022.
• Average Other Operating Expenses over 5 years is $24.3 million, with a median of $23.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 65.75% in 2022, then fell 3.87% in 2023.
• Over 5 years, Other Operating Expenses stood at $17.9 million in 2022, then climbed by 11.39% to $20.0 million in 2023, then advanced by 22.93% to $24.5 million in 2024, then climbed by 15.27% to $28.3 million in 2025, then advanced by 27.17% to $36.0 million in 2026.
• The last three Other Operating Expenses figures came in at $36.0 million (Q2 2026), $35.8 million (Q1 2026), and $28.3 million (Q4 2025), per Business Quant data.